AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-137076520/sugar-free-actiq-o.html" title="Facts and information about Sugar-free Actiq O.K.'d.(Branded Drugs)(Cephalon Inc. approved for marketing Actiq)(Brief Article)">Sugar-free Actiq O.K.'d.(Branded Drugs)(Cephalon Inc. approved for marketing Actiq)(Brief Article)</a>
Close
Set up an RSS feed that alerts you when new articles from Chain Drug Review are available.
Frequently asked questions about RSS feeds
Sugar-free Actiq O.K.'d.(Branded Drugs)(Cephalon Inc. approved for marketing Actiq)(Brief Article)
Cephlon Inc. has received FDA approval to market a sugar-free formulation of Actiq. The company hopes to launch the medicated lozenge, for the management of pain in cancer patients, during the ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- U.S. FDA Clears Actiq for Breakthrough Cancer Pain; First Product Approved for...
- Press release article from: PR Newswire November 5, 1998 700+ words
...that the U.S. Food and Drug Administration (FDA) has cleared Actiq(R) (oral transmucosal fentanyl citrate) for marketing. Actiq is the first product specifically designed and studied for breakthrough cancer pain. It is indicated only for the management...
- Warning issued on Cephalon painkiller.
- Newspaper article from: Philadelphia Inquirer (Philadelphia, PA) September 27, 2007 700+ words
...and state investigators raised concerns about Cephalon's promotion of its narcotic drug Actiq. The company has denied marketing Actiq and other drugs outside FDA-approved uses. However, its promotion practices have come under scrutiny by the U.S...
- $425 Million Cephalon Civil Settlement and Criminal Fine; In America's Largest...
- Press release article from: PR Newswire September 29, 2008 700+ words
...many schemes to support off-label marketing alleged in the relators' and Government Complaints are: -- Intensively marketing Actiq to physical medicine and rehabilitation, and pain management specialists; -- Encouraging sales reps to make false statements...